Arzeda

Arzeda, also known as The Protein Design Company (TM), is a biotechnology startup founded in 2009. The company specializes in synthetic biology, creating novel proteins, enzymes, and specialty chemical products that are designed to compete on performance, cost, and sustainability. Operating at the intersection of biotechnology, information technology, and manufacturing, Arzeda has garnered attention for its innovative approach to creating valuable and sustainable molecules. With its headquarters in the United States, Arzeda has become a key player in the development of enzymes and specialty chemicals for various industries, including polymers, pharmaceuticals, and industrial chemicals. The startup has also established strategic partnerships with Fortune 500 companies, solidifying its position in the market and enabling further growth and expansion. A significant milestone for Arzeda was the recent $14.94M Venture Round investment received on 13 November 2023. While the specific investors for this round are not disclosed, this injection of capital is a testament to the confidence that the market has in Arzeda's capabilities and potential. This funding is expected to fuel the company's continued innovation and progression in the biotechnology and manufacturing sectors. For more detailed information, interested parties can visit Arzeda's website at www.arzeda.com. As the company continues to navigate the intersection of biotechnology, information technology, and manufacturing, its trajectory and impact on the sustainable production of valuable molecules make it a noteworthy player in the startup ecosystem.